Anagrelide-13C2,15N,d2 | MedChemExpress (MCE)
Anagrelide-13C2,15N,d2 is 15N and deuterated labeled Anagrelide (HY-B0523). Anagrelide is a potent inhibitor of phosphodiesterase type III (PDE3) (IC50=36?nM). Anagrelide, an imidazoquinazoline derivative, acts as an inhibitor of platelet aggregation. Anagrelide inhibits bone marrow megakaryocytopoiesis. Anagrelide decreases gastrointestinal stromal tumor (GIST) cell proliferation and promotes their apoptosis in vitro. Anagrelide is a platelet-lowering agent and plays in the antithrombopoietic action[1][2][3].
Trivial name | Anagrelide-13C2,15N,d2 |
Catalog Number | HY-B0523S |
Research Area | Cardiovascular Disease; Cancer |
Purity | ≥98.0% |
SMILES | O=[13C]1CC2NC3=C(C(Cl)=C(Cl)C=C3)C([2H])([2H])[15N]2[13CH2]1 |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/anagrelide-13c2-15n-d2.html |